Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology

Background/Aim: We investigated the prognostic impact of hemoglobin (Hb) levels in tumour patients receiving routine cardiological surveillance during anticancer treatment. The aim of the study was to identify independent predictors of all-cause mortality in a cardio-oncological collective. Patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hohneck, Anna (VerfasserIn) , Rosenkaimer, Stephanie L. (VerfasserIn) , Sieburg, Tina (VerfasserIn) , Holzwarth, Jakob (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn) , Akın, Ibrahim (VerfasserIn) , Borggrefe, Martin (VerfasserIn) , Gerhards, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2021
In: Anticancer research
Year: 2021, Jahrgang: 41, Heft: 1, Pages: 369-378
ISSN:1791-7530
DOI:10.21873/anticanres.14785
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.21873/anticanres.14785
Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/41/1/369
Volltext
Verfasserangaben:Anna Hohneck, Stephanie Rosenkaimer, Tina Sieburg, Jakob Holzwarth, Ralf D. Hofheinz, Ibrahim Akin, Martin Borggrefe, Stefan Gerhards

MARC

LEADER 00000caa a2200000 c 4500
001 1759327743
003 DE-627
005 20220819220839.0
007 cr uuu---uuuuu
008 210601s2021 xx |||||o 00| ||eng c
024 7 |a 10.21873/anticanres.14785  |2 doi 
035 |a (DE-627)1759327743 
035 |a (DE-599)KXP1759327743 
035 |a (OCoLC)1341414949 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hohneck, Anna  |d 1990-  |e VerfasserIn  |0 (DE-588)1194587674  |0 (DE-627)1676810412  |4 aut 
245 1 0 |a Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology  |c Anna Hohneck, Stephanie Rosenkaimer, Tina Sieburg, Jakob Holzwarth, Ralf D. Hofheinz, Ibrahim Akin, Martin Borggrefe, Stefan Gerhards 
264 1 |c January 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.06.2021 
520 |a Background/Aim: We investigated the prognostic impact of hemoglobin (Hb) levels in tumour patients receiving routine cardiological surveillance during anticancer treatment. The aim of the study was to identify independent predictors of all-cause mortality in a cardio-oncological collective. Patients and Methods: A total of 551 patients (273 males, 278 females) were enrolled in the Mannheim Registry for Cardiooncology and were included in the present analysis. Median follow-up was 41 months (95% CI=40-43). Results: Patients were grouped according to a pretherapeutic Hb-threshold (determined by ROC analysis) into cohorts with Hb<11.4 g/dl (n=232, 42.1%) and Hb >11.4 g/dl (n=319, 57.9%). Patients with lower Hb levels were older at the time of first diagnosis (63.8±14.4 vs. 59.9±15.4 years, p=0.003) and were more likely to have advanced tumour stages (92 (39.7%) vs. 83 (26.0%), p=0.0007). There were no differences regarding cardiovascular comorbidities such as hypertension or diabetes, while chronic kidney disease was more common in patients with lower Hb. Anticoagulants were used more often in patients with lower Hb (88 (37.9%) vs. 84 (26.3%), p=0.01). Left ventricular ejection fraction (LVEF) was lower in patients with Hb <11.4 g/dl (51.9±11.0% vs. 55.1±9.7%, p=0.003). Correlation analysis revealed a significant correlation of Hb levels and LVEF (R2=0.07, p<0.0001). During follow-up, a total of 140 patients (25.4%) were deceased, with significantly more deaths occurring in the group of patients with low Hb values [108 (46.6%) vs. 32 (10.0%), p<0.0001]. In multivariable analysis, Hb was identified as independent predictor for mortality (OR=5.3, CI=0.41-0.89, p<0.0001). Conclusion: Low Hb levels were identified as an independent predictor of mortality in patients with cancer. There was a significant correlation of Hb and LVEF, suggesting that low Hb values are not solely due to anaemia, but rather reflect the severity of cancer. 
650 4 |a Cancer-related anaemia 
650 4 |a heart failure 
650 4 |a hemoglobin 
650 4 |a mortality 
700 1 |a Rosenkaimer, Stephanie L.  |d 1976-  |e VerfasserIn  |0 (DE-588)1214270085  |0 (DE-627)1725244314  |4 aut 
700 1 |a Sieburg, Tina  |d 1964-  |e VerfasserIn  |0 (DE-588)1234495317  |0 (DE-627)175932583X  |4 aut 
700 1 |a Holzwarth, Jakob  |d 1987-  |e VerfasserIn  |0 (DE-588)1234496291  |0 (DE-627)1759327565  |4 aut 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
700 1 |a Akın, Ibrahim  |d 1978-  |e VerfasserIn  |0 (DE-588)132322293  |0 (DE-627)521039010  |0 (DE-576)299074366  |4 aut 
700 1 |a Borggrefe, Martin  |e VerfasserIn  |0 (DE-588)1025920546  |0 (DE-627)725574232  |0 (DE-576)370913426  |4 aut 
700 1 |a Gerhards, Stefan  |d 1979-  |e VerfasserIn  |0 (DE-588)139524398  |0 (DE-627)611814579  |0 (DE-576)312148259  |4 aut 
773 0 8 |i Enthalten in  |t Anticancer research  |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004  |g 41(2021), 1, Seite 369-378  |h Online-Ressource  |w (DE-627)387478493  |w (DE-600)2145376-7  |w (DE-576)358408717  |x 1791-7530  |7 nnas  |a Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology 
773 1 8 |g volume:41  |g year:2021  |g number:1  |g pages:369-378  |g extent:10  |a Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology 
856 4 0 |u https://doi.org/10.21873/anticanres.14785  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ar.iiarjournals.org/content/41/1/369  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210601 
993 |a Article 
994 |a 2021 
998 |g 139524398  |a Gerhards, Stefan  |m 139524398:Gerhards, Stefan  |d 60000  |d 61000  |e 60000PG139524398  |e 61000PG139524398  |k 0/60000/  |k 1/60000/61000/  |p 8  |y j 
998 |g 1025920546  |a Borggrefe, Martin  |m 1025920546:Borggrefe, Martin  |d 60000  |d 61000  |e 60000PB1025920546  |e 61000PB1025920546  |k 0/60000/  |k 1/60000/61000/  |p 7 
998 |g 132322293  |a Akın, Ibrahim  |m 132322293:Akın, Ibrahim  |d 60000  |d 61000  |e 60000PA132322293  |e 61000PA132322293  |k 0/60000/  |k 1/60000/61000/  |p 6 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 65500  |e 60000PH121917517  |e 65500PH121917517  |k 0/60000/  |k 1/60000/65500/  |p 5 
998 |g 1234496291  |a Holzwarth, Jakob  |m 1234496291:Holzwarth, Jakob  |d 60000  |d 61000  |e 60000PH1234496291  |e 61000PH1234496291  |k 0/60000/  |k 1/60000/61000/  |p 4 
998 |g 1234495317  |a Sieburg, Tina  |m 1234495317:Sieburg, Tina  |d 60000  |d 61000  |e 60000PS1234495317  |e 61000PS1234495317  |k 0/60000/  |k 1/60000/61000/  |p 3 
998 |g 1214270085  |a Rosenkaimer, Stephanie L.  |m 1214270085:Rosenkaimer, Stephanie L.  |d 60000  |d 61000  |e 60000PR1214270085  |e 61000PR1214270085  |k 0/60000/  |k 1/60000/61000/  |p 2 
998 |g 1194587674  |a Hohneck, Anna  |m 1194587674:Hohneck, Anna  |d 60000  |d 61000  |e 60000PH1194587674  |e 61000PH1194587674  |k 0/60000/  |k 1/60000/61000/  |p 1  |x j 
999 |a KXP-PPN1759327743  |e 3933596858 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.21873/anticanres.14785"],"eki":["1759327743"]},"name":{"displayForm":["Anna Hohneck, Stephanie Rosenkaimer, Tina Sieburg, Jakob Holzwarth, Ralf D. Hofheinz, Ibrahim Akin, Martin Borggrefe, Stefan Gerhards"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 01.06.2021"],"title":[{"title_sort":"Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology","title":"Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology"}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"January 2021"}],"relHost":[{"origin":[{"dateIssuedDisp":"2004-","dateIssuedKey":"2004","publisherPlace":"Kapandriti, Attiki, Greece","publisher":"International Institute of Anticancer Research"}],"title":[{"subtitle":"international journal of cancer research and treatment","title":"Anticancer research","title_sort":"Anticancer research"}],"note":["Gesehen am 26.02.13"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"387478493","physDesc":[{"extent":"Online-Ressource"}],"disp":"Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncologyAnticancer research","pubHistory":["Nachgewiesen 24.2004 -"],"name":{"displayForm":["International Institute of Anticancer Research"]},"part":{"year":"2021","volume":"41","pages":"369-378","text":"41(2021), 1, Seite 369-378","extent":"10","issue":"1"},"id":{"eki":["387478493"],"issn":["1791-7530"],"zdb":["2145376-7"]}}],"person":[{"family":"Hohneck","role":"aut","given":"Anna","display":"Hohneck, Anna"},{"display":"Rosenkaimer, Stephanie L.","role":"aut","given":"Stephanie L.","family":"Rosenkaimer"},{"display":"Sieburg, Tina","role":"aut","given":"Tina","family":"Sieburg"},{"family":"Holzwarth","role":"aut","given":"Jakob","display":"Holzwarth, Jakob"},{"role":"aut","given":"Ralf-Dieter","family":"Hofheinz","display":"Hofheinz, Ralf-Dieter"},{"display":"Akın, Ibrahim","family":"Akın","role":"aut","given":"Ibrahim"},{"family":"Borggrefe","given":"Martin","role":"aut","display":"Borggrefe, Martin"},{"family":"Gerhards","role":"aut","given":"Stefan","display":"Gerhards, Stefan"}],"physDesc":[{"extent":"10 S."}],"recId":"1759327743"} 
SRT |a HOHNECKANNPROGNOSTIC2021